Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis

References

• Lemp MA, Nichols KK. Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment. Ocul Surf 2009;7(2 Suppl.):S1-S14
   PubMed Web of Science ®Google Scholar
• Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol 2008;43:170-9
   PubMed Web of Science ®Google Scholar
• Thygeson P. Etiology and treatment of blepharitis. A study in military personnel. Arch Ophthalmol 1946;36:445-57
   Web of Science ®Google Scholar
• Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol 1984;68:524-8
   PubMed Web of Science ®Google Scholar
• Groden LR, Murphy B, Rodnite J, et al. Lid flora in blepharitis. Cornea 1991;10:50-3
   PubMed Web of Science ®Google Scholar
• McCulley JP, Dougherty JM. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc UK 1986;105(Pt 3):314-8
   PubMedGoogle Scholar
• Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci 1986;27:486-91
   PubMed Web of Science ®Google Scholar
• Novick RP. Interrupters on the bacterial party line. Nat Chem Biol 2005;1:321-2
   PubMed Web of Science ®Google Scholar
• Wright JS 3rd, Jin R, Novick RP. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci USA. 2005;102:1691-6
   PubMed Web of Science ®Google Scholar
• Abelson MB, Workman A, Taylor A. Eavesdropping in blepharitis: Once the bacteria start talking, the news they share may turn out to be bad. Rev Ophthalmol 2007;14(10):92-6
   Google Scholar
• McCulley JP. Blepharoconjunctivitis. Int Ophthalmol Clin 1984;24:65-77
   PubMedGoogle Scholar
• McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-80
   PubMed Web of Science ®Google Scholar
• Smith RE, Flowers CW Jr. Chronic blepharitis: a review. CLAO J 1995;21:200-7
   PubMedGoogle Scholar
• Mathers WD, Choi D. Cluster analysis of patients with ocular surface disease, blepharitis, and dry eye. Arch Ophthalmol 2004;122:1700-4
   PubMed Web of Science ®Google Scholar
• InSite Vision. Comparative study of Azasite Plus compared to Azasite alone and dexamethasone alone to treat subjects with blepharoconjunctivitis. Bethesda (MD): National Library of Medicine (US). Available at: http://clinicaltrials.gov/ct2/show/NCT00578955 [Last accessed 29 September 2010]
   Google Scholar
• Ora, Inc. A single-center, double-masked, randomized, vehicle controlled study to evaluate the safety and efficacy of testosterone 0.03% ophthalmic solution compared to vehicle for the treatment of meibomian gland dysfunction. Bethesda (MD): National Library of Medicine (US). Available at: http://clinicaltrials.gov/ct2/show/NCT00755183 [Last accessed 29 September 2010]
   Google Scholar
• Huber-Spitzy V, Baumgartner I, Böhler-Sommeregger K, et al. Blepharitis – a diagnostic and therapeutic challenge. A report on 407 consecutive cases. Graefes Arch Clin Exp Ophthalmol 1991;229:224-7
   PubMed Web of Science ®Google Scholar
• Denton P, Barequet IS, and O’Brien TP. Therapy of infectious blepharitis. Ophthalmology 1999;12:9-14
   Google Scholar
• Seal DV, McGill JI, Jacobs P, et al. Microbial and immunological investigations of chronic non-ulcerative blepharitis and meibomianitis. Br J Ophthalmol 1985;69:604-11
   PubMed Web of Science ®Google Scholar
• Gilbard JP. Dry eye and blepharitis: approaching the patient with chronic eye irritation. Geriatrics 2009;64:22-6
   PubMed Web of Science ®Google Scholar
• John T, Shah AA. Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis. Ann Ophthalmol (Skokie) 2008;40:68-74
   PubMed Web of Science ®Google Scholar
• Haque RM, Torkildsen GL, Brubaker K, et al. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea 2010;29:871-7
   Google Scholar
• Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther 2008;25:858-70
   PubMed Web of Science ®Google Scholar
• Inspire Pharmaceuticals. Inspire Announces Results From AZASITE(R) Phase 2 Blepharitis Trials And Plans To Continue Clinical Development In Anterior And Posterior Blepharitis. Medical News Today. March 17, 2010. Available at: http://www.medicalnewstoday.com/articles/182501.php. [Accessed November 3, 2010]
   Google Scholar
• Inspire Pharmaceuticals. The effects of azithromycin ophthalmic solution, 1% versus placebo in subjects with blepharitis during a four-week treatment period. Bethesda (MD): National Library of Medicine (US), 2009. Available at: http://clinicaltrials.gov/ct2/show/NCT00894530 [Last accessed 3 November 2010]
   Google Scholar
• Inspire Pharmaceuticals. The effects of azithromycin ophthalmic solution, 1% versus placebo in subjects with blepharitis during a two-week treatment period. Bethesda (MD): National Library of Medicine (US), 2010. Available at: http://clinicaltrials.gov/ct2/show/NCT00892970 [Last accessed 3 November 2010]
   Google Scholar
• Weijtens O, Schoemaker RC, Romijn FP, et al. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology 2002;109:1887-91.28.
   PubMed Web of Science ®Google Scholar
• Pelletier JS, Stewart K, Trattler W, et al. A combination povidone–iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther 2009;26:776-83
   PubMed Web of Science ®Google Scholar
• Awan MA, Agarwal PK, Watson DG, et al. Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance. Br J Ophthalmol 2009;93:708-13
   PubMed Web of Science ®Google Scholar
• Holland EJ, Bartlett JD, Paterno MR, et al. Effects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraocular pressure in healthy volunteers. Cornea 2008;27:50-5
   PubMed Web of Science ®Google Scholar
• Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med 2004;117(Suppl. 9A):5S-11S
   PubMedGoogle Scholar
• Zalewska-Kaszubska J, Gorska D. Anti-inflammatory capabilities of macrolides. Pharmacol Res 2001;44:451-4
   PubMed Web of Science ®Google Scholar
• Ianaro A, Ialenti A, Maffia P, et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000;292:156-63
   PubMed Web of Science ®Google Scholar
• Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids – new mechanisms for old drugs. N Engl J Med 2005;353:1711-23
   PubMed Web of Science ®Google Scholar
• Cheung PS, Si EC, Hosseini K. Anti-inflammatory activity of azithromycin as measured by its NF-kappaB, inhibitory activity. Ocul Immunol Inflamm 2010;18:32-7
   PubMed Web of Science ®Google Scholar